Find clinical trials for COVID-19 in Salt Lake City, UT

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Coronavirus Infections

Infections

Post-Acute COVID-19 Syndrome

Human Influenza

Pneumonia

Respiratory Tract Infections

Virus Diseases

COVID-19 trials near Salt Lake City, UT, USA:

Impact of Reactogenicity of the 2024-2025 COVID-19 Vaccines on Health Care Workers and First Responders in the United States (SHIELD)

To assess the impact of reactogenicity among health care workers and first responders receiving an updated 2024-25 Novavax COVID-19-...

Active, not recruiting

COVID-19

SARS CoV 2 Infection

Biological: Pfizer mRNA COVID-19 vaccine

Biological: protein subunit: Novavax COVID-19 vaccine

Phase 4

Novavax

Salt Lake City, Utah, United States

A Phase 2b, Randomized, Double-blind, Active-controlled Study of Single Dose CVXGA Intranasal COVID-19 Vaccine in Adults

The purpose of this trial is to assess the safety and relative efficacy of CVXGA (CVXGA50), a KP.2 containing vaccine, compared to COMIRNATY® (COVID...

Active, not recruiting

COVID-19

Biological: CVXGA (CVXGA50)

Biological: COMIRNATY®

Phase 2

Cyanvac

West Jordan, Utah, United States and 54 other locations

A Study to Evaluate VXA-CoV2-3.3 COVID-19 Vaccine Against Currently Approved/Authorized mRNA COVID-19 Injectable Booster Vaccine in Adults Previously Immunized Against COVID-19 Infection

vaccine for the prevention of symptomatic Coronavirus Disease 2019 (COVID-19).In order to represent a more recently circulating SAR...

Active, not recruiting

COVID-19

SARS-CoV2

Biological: VXA-CoV2-3.1

Biological: VXA-CoV2-3.3

Phase 2

Vaxart

Salt Lake City, Utah, United States and 144 other locations

Status recently updated

Efficacy and Safety of NVX-CoV2705 (COVID-19)

This is a Phase 4, post-market US study, evaluating the efficacy and safety of a single dose of the NVX-CoV2705 Omicron JN.1 COVID-19...

Not yet enrolling

Active, not recruiting

COVID-19

Sars-CoV-2 Infection

Biological: NVX-CoV2705

Biological: Placebo

Phase 4

Novavax

Salt Lake City, Utah, United States and 98 other locations

A Study to Learn About BNT162b2 (LP.8.1)-Adapted Vaccine Against SARS-CoV-2 in Children 5 Through 11 Years of Age That Are Considered at Higher Risk of Severe COVID-19

The purpose of this study is to learn about the safety, tolerability, and immunogenicity of an updated vaccine against COVID-19, ca-...

Active, not recruiting

COVID-19

SARS-COV-2 Infection

Biological: BNT162b2 (2025/2026 formulation)

Phase 3

BioNTech

Salt Lake City, Utah, United States and 30 other locations

A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease

The purpose of the study is to evaluate whether ibuzatrelvir is effective and safe in adults and adolescents with COVID-19 who do n...

Enrolling

COVID-19 SARS-CoV-2 Infection

Drug: placebo

Drug: ibuzatrelvir

Phase 3

Pfizer

Clinton, Utah, United States of America and 131 other locations

A Study to Learn About COVID-19 RNA-Based Variant-Adapted Vaccine Candidate(s) Against SARS-CoV-2 in Participants Ages 12 Through 64 Years Considered at Higher Risk of Severe COVID-19, and Participants Ages ≥65 Years

The purpose of this study is to learn about the safety, tolerability, and immunogenicity of an updated vaccine against COVID-19.Thi-...

Active, not recruiting

COVID-19

SARS-COV-2 Infection

Biological: BNT162b2 (2025/2026 recommended SARS-CoV-2 strain)

Phase 3

BioNTech

Salt Lake City, Utah, United States and 18 other locations

EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease

study treatment works in the study) of the study medicine (called nirmatrelvir/ritonavir) for potential treatment of coronavirus disease 2019 (COVID...

Enrolling

COVID-19

Drug: nirmatrelvir

Drug: ritonavir

Phase 3

Pfizer

Salt Lake City, Utah, United States and 75 other locations

Safety and Immunogenicity of NVX-CoV2705 (COVID-19)

This study is a Phase 3 trial designed to check the safety and immune response to a new Omicron JN.1 COVID-19 vaccine. Study resear-...

Active, not recruiting

COVID-19

SARS-CoV-2 Infection

Biological: NVX-CoV2705

Phase 3

Sanofi

Pleasant View, Utah, United States and 9 other locations

A Study to Evaluate the Efficacy and Safety of mRNA-1283 and mRNA-1273 in Participants 50 to 64 Years of Age Without High-Risk Conditions for Severe Coronavirus Disease 2019 (COVID-19)

the efficacy and safety of mRNA-1283 and mRNA-1273 (variant formulations) in adults 50 to 64 years of age without high risk factors for severe COVID...

Active, not recruiting

SARS-CoV-2

Biological: mRNA-1283

Biological: mRNA-1273

Phase 4

Moderna

Salt Lake City, Utah, United States and 149 other locations

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms

Find clinical trials for COVID-19 in .css-epvm6{white-space:nowrap;}Salt Lake City, UT

Related conditions:

COVID-19 trials near Salt Lake City, UT, USA:

Impact of Reactogenicity of the 2024-2025 COVID-19 Vaccines on Health Care Workers and First Responders in the United States (SHIELD)

A Phase 2b, Randomized, Double-blind, Active-controlled Study of Single Dose CVXGA Intranasal COVID-19 Vaccine in Adults

A Study to Evaluate VXA-CoV2-3.3 COVID-19 Vaccine Against Currently Approved/Authorized mRNA COVID-19 Injectable Booster Vaccine in Adults Previously Immunized Against COVID-19 Infection

Efficacy and Safety of NVX-CoV2705 (COVID-19)

A Study to Learn About BNT162b2 (LP.8.1)-Adapted Vaccine Against SARS-CoV-2 in Children 5 Through 11 Years of Age That Are Considered at Higher Risk of Severe COVID-19

A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease

A Study to Learn About COVID-19 RNA-Based Variant-Adapted Vaccine Candidate(s) Against SARS-CoV-2 in Participants Ages 12 Through 64 Years Considered at Higher Risk of Severe COVID-19, and Participants Ages ≥65 Years

EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease

Safety and Immunogenicity of NVX-CoV2705 (COVID-19)

A Study to Evaluate the Efficacy and Safety of mRNA-1283 and mRNA-1273 in Participants 50 to 64 Years of Age Without High-Risk Conditions for Severe Coronavirus Disease 2019 (COVID-19)

Find clinical trials for COVID-19 in Salt Lake City, UT